Casandra
Casandra Test Code QD89945Version 1 (DRAFT)
Performing Lab
CDX2, IHC without Interpretation
Clinical Use
Order TestUse
CDX‑2, a nuclear transcription factor expressed in colonic epithelium, is useful in distinguishing metastatic carcinoma of colorectal origin from other tumors. However, its expression may be lost in advanced colorectal tumors and is also expressed by some mucinous tumors of other sites.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (IHC)
Biomarkers
CDX2
ProteinIHC
Expression • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
IHC specimen transport kit
Collection Instructions
Formalin‑fixed paraffin embedded tissue; unstained charged (+) slides collected in IHC specimen transport kit (x5)
Causes for Rejection
Received frozen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinite |
| Refrigerated | Indefinite |
| Frozen | Unacceptable |
Similar Tests
Other tests from different labs that may be relevant
CDX2
NeoGenomics
CDX2, technical only
MPLN
CDX2
MPLN
CDX2 Immunostain, Technical Component Only
Mayo Clinic Lab
CDX2 by Immunohistochemistry
ARUP Laboratories
MUC2
NeoGenomics
Carbonic Anhydrase IX (CA IX)
NeoGenomics
Carcinoembryonic Antigen, Monoclonal Immunostain, Technical Component Only
Mayo Clinic Lab
Mismatch Repair (MMR) IHC Panel
NeoGenomics
CEA (Mono)
NeoGenomics
